#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14992	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2650	698.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1792	1792	C	970	C	970	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25358	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3906	808.1	0	.	n	.	0	T695C	SNP	695	695	T	1194	1194	C	963	C,T,A	958,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25358	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3906	808.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1836	1836	A	1036	A,C,T	1031,4,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25358	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3906	808.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2470	2470	C	890	C	890	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25358	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3906	808.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3096	3096	T	848	T,C	847,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25358	23S	2890	2890	99.86	23S.l15.c17.ctg.1	3906	808.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2544	2544	A	740	A	740	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	V36A	NONSYN	106	108	GTG	634	636	GCG	216;216;217	G,T,C;C,G;G	214,1,1;215,1;217	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	676	678	CGG	224;225;224	C;G;G	224;225;224	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	S68L	NONSYN	202	204	TCG	730	732	TTG	177;174;173	T,G;T;G	176,1;174;173	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	A90V	NONSYN	268	270	GCG	796	798	GTT	122;122;121	G;T,G;T	122;121,1;121	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	I105V	NONSYN	313	315	ATT	841	843	GTT	132;133;135	G;T;T	132;133;135	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	N125T	NONSYN	373	375	AAT	901	903	ACC	174;180;181	A;C,T;C	174;179,1;181	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	R135C	NONSYN	403	405	CGT	931	933	TGT	202;204;204	T;G;T	202;204;204	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	K151E	NONSYN	451	453	AAA	979	981	GAA	195;196;197	G,A;A,C;A	194,1;194,2;197	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	T152N	NONSYN	454	456	ACC	982	984	AAC	197;198;199	A;A;C	197;198;199	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	A172T	NONSYN	514	516	GCG	1042	1044	ACA	173;175;174	A,T;C;A	172,1;175;174	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	A175E	NONSYN	523	525	GCG	1051	1053	GAA	177;176;175	G,T,A;A;A	175,1,1;176;175	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	E176T	NONSYN	526	528	GAA	1054	1056	ACC	174;175;174	A;C,A;C	174;174,1;174	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	I178V	NONSYN	532	534	ATC	1060	1062	GTC	173;170;171	G;T,G;C,G	172;168,1;169,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	I188T	NONSYN	562	564	ATA	1090	1092	ACG	184;183;178	A;C;G,T	184;183;177,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	P200N	NONSYN	598	600	CCC	1126	1128	AAC	138;136;136	A;A;C	138;136;136	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	F220L	NONSYN	658	660	TTT	1186	1188	TTG	130;130;122	T,G;T;G	129,1;130;122	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1243	1245	ACC	141;142;143	A;C;C	141;142;143	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1246	1248	GAC	146;145;144	G,T;A;C	145,1;145;144	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1255	1257	GCG	150;152;152	G;C;G	150;152;152	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1291	1293	GCT	149;151;155	G;C,A;T,C	149;150,1;154,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1638	folP	858	858	91.61	folP.l15.c4.ctg.1	1944	105.1	1	SNP	p	R230S	1	.	.	688	690	AGC	1216	1218	AGC	119;121;121	A;G;C,T	119;121;120,1	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5300	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4023	164.3	1	SNP	p	S91F	0	.	.	271	273	TCC	989	991	TCC	201;201;202	T;C;C	201;201;202	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5300	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4023	164.3	1	SNP	p	D95G	0	.	.	283	285	GAC	1001	1003	GAC	199;198;197	G;A;C	199;198;197	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5300	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4023	164.3	1	SNP	p	D95N	0	.	.	283	285	GAC	1001	1003	GAC	199;198;197	G;A;C	199;198;197	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	27	1884	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1732	135.6	1	SNP	p	G45D	0	.	.	133	135	GGC	702	704	GGC	227;223;224	G,T;G;C	226,1;223;224	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1156	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1354	106.2	0	.	n	.	0	.206T	INS	206	206	T	756	756	T	229	T	229	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5296	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3429	192.6	1	SNP	p	D86N	0	.	.	256	258	GAC	829	831	GAC	236;234;235	G;A,C;C	236;232,2;235	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5296	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3429	192.6	1	SNP	p	S87W	0	.	.	259	261	AGT	832	834	AGT	234;232;232	A,G,C;G;T	232,1,1;232;232	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5296	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3429	192.6	1	SNP	p	S87R	0	.	.	259	261	AGT	832	834	AGT	234;232;232	A,G,C;G;T	232,1,1;232;232	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5296	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3429	192.6	1	SNP	p	S87I	0	.	.	259	261	AGT	832	834	AGT	234;232;232	A,G,C;G;T	232,1,1;232;232	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5296	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3429	192.6	1	SNP	p	S88P	0	.	.	262	264	TCC	835	837	TCC	231;231;233	T,G;C;C	230,1;231;232	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4376	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3086	176.8	0	.	p	.	0	A386T	NONSYN	1156	1158	GCC	1725	1727	ACC	260;261;261	A;C;C,A	260;261;260,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4376	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3086	176.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1797	1799	GGC	250;247;244	G;G;C,A	250;247;243,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4040	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2815	178.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1480	1482	GCA	227;229;230	G,A;C;A	226,1;229;230	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4040	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2815	178.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1483	1485	ATC	227;227;229	A;T;C	227;227;229	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4040	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2815	178.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1495	1497	GTG	223;224;228	G;T,A;G	223;223,1;228	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4040	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2815	178.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1495	1497	GTG	223;224;228	G;T,A;G	223;223,1;228	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4040	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2815	178.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1999	2001	ACC	189;187;185	A;C,T;C	189;186,1;185	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4040	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2815	178.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2053	2055	GCG	198;198;197	G;C;G,T	198;198;195,2	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4040	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2815	178.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2053	2055	GCG	198;198;197	G;C;G,T	198;198;195,2	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4040	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2815	178.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2176	2178	GGC	195;198;198	G;G;C	195;198;198	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4040	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2815	178.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2185	2187	GGC	196;201;203	G,T;G;C	195,1;201;203	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4040	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2815	178.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2203	2205	CCG	197;197;193	C,G;C;G	196,1;197;193	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5614	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3441	203.3	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1822	1824	CTG	242;242;239	C,T;T,G;G,T	241,1;241,1;238,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2328	porA	1146	1146	99.83	porA.l6.c4.ctg.1	2326	124.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	861	861	C	191	C,G,A	189,1,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	G38E	NONSYN	112	114	GGA	540	542	GAA	284;286;290	G,T,A;A;A	282,1,1;286;290	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	T87A	NONSYN	259	261	ACT	687	689	GCT	214;213;210	G,T;C,A;T,A	213,1;212,1;209,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	T89S	NONSYN	265	267	ACC	693	695	AGC	209;212;213	A,G,C;G;C	207,1,1;212;213	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	.	MULTIPLE	358	359	AA	785	786	CG	229;229	C;G	229;229	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	.	MULTIPLE	361	362	GA	788	790	CAG	231;233;238	C;A;G	231;233;238	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	N122K	NONSYN	364	366	AAC	792	794	AAA	230;229;231	A;A;A	230;229;231	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	K143E	NONSYN	427	429	AAA	855	857	GAA	223;228;229	G,A;A;A,C	222,1;228;228,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	V151A	NONSYN	451	453	GTA	879	881	GCA	231;233;232	G;C,T;A	231;232,1;232	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	N212D	NONSYN	634	636	AAT	1062	1064	GAT	218;216;211	G;A;T	218;216;211	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	D213G	NONSYN	637	639	GAT	1065	1067	GGT	206;203;203	G,T;G;T	205,1;203;203	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	I218M	NONSYN	652	654	ATA	1080	1082	ATG	200;202;200	A;T;G	200;202;200	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1194	1196	GCA	220;219;219	G;C,T;A	220;218,1;219	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1197	1199	ACG	216;216;217	A;C;G,C	216;216;216,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	R258G	NONSYN	772	774	CGT	1200	1202	GGG	217;220;220	G;G;G	217;220;220	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1203	1205	GTT	221;219;217	G;T;T	221;219;217	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1263	1265	GTA	223;222;222	G,T;T;A	222,1;222;222	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1302	1304	ACT	224;224;224	A;C,T;T	224;223,1;224	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1308	1310	GAT	227;229;231	G;A;T,G	227;229;230,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1320	1322	CAC	242;241;243	C;A;C	242;241;243	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	1	SNP	p	G120K	1	.	.	358	360	AAG	785	787	CGG	229;229;231	C;G;G,T	229;229;230,1	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	1	SNP	p	A121D	1	.	.	361	363	GAC	788	791	CGC	231;238;234	C;G;C	231;238;234	porB1b.WHO_Z_02266c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2772	porB1b	1047	1047	97.14	porB1b.l15.c30.ctg.1	1616	208.3	1	SNP	p	D121N	0	.	.	361	363	GAC	788	791	CGC	231;238;234	C;G;C	231;238;234	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10310	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5270	243.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2221	2223	CAT	282;282;284	C,T;A,T;T,G	281,1;281,1;283,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1498	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1589	117.6	1	SNP	p	V57M	1	.	.	169	171	ATG	863	865	ATG	275;270;270	A,G;T,C;G	274,1;269,1;270	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
